Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 274

The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.

Mechanisms of Cardioprotection by Volatile Anesthetics

Tanaka, Katsuya, Ludwig, Lynda M., Kersten, Judy R., Pagel, Paul S., Warltier, David C.·2004·Anesthesiology

Abstract

Received from the Departments of Anesthesiology, Pharmacology and Toxicology, and Medicine (Division of Cardiovascular Diseases), Medical College of Wisconsin, Milwaukee, Wisconsin; the Clement J. Zablocki Veterans Affairs Medical Center, Milwaukee, Wisconsin; and the Department of Biomedical Engineering, Marquette University, Milwaukee, Wisconsin.A RAPIDLY growing body of evidence indicates that volatile anesthetics protect myocardium against reversible and irreversible ischemic injury. Identifying the mechanisms by which volatile agents mediate these antiischemic actions is the subject of intense research. This objective has been difficult to accomplish because volatile anesthetics also profoundly affect cardiovascular function. Volatile agents reduce arterial and coronary perfusion pressure, cause dose-related depression of myocardial contractility, produce coronary vasodilation, affect electrophysiologic function, and modify autonomic nervous system activity to varying degrees. Therefore, the antiischemic effects of volatile anesthetics may be mediated, at least in part, by favorable alterations in myocardial oxygen supply-demand relations, preservation of energy-dependent cellular functions, and increased coronary blood flow. However, it seems unlikely that changes in myocardial metabolism and coronary perfusion caused by volatile anesthetics are solely responsible for protection against ischemic damage. Instead, several endogenous signal transduction pathways, acting through the adenosine triphosphate (ATP)-sensitive potassium (KATP) channel and involving the generation of reactive oxygen species (ROS), have been implicated in mediating the antiischemic actions of volatile anesthetics. The experimental and clinical findings documenting the phenomenon of volatile anesthetic preconditioning against ischemic injury of myocardium are evaluated. Recent findings in vitro and in vivo that seek to define the intracellular mechanisms responsible for these beneficial actions are also summarized.The antiischemic effects of volatile anesthetics were initially proposed more than 20 yr ago. Lowenstein et al. 1demonstrated that halothane reduced ST segment elevation in a canine model of brief coronary artery occlusion. These data were consistent with the hypothesis that exposure to halothane reduced acute ischemic injury. A subsequent study by this research group also demonstrated that halothane reduced myocardial infarct size when administered before prolonged coronary artery occlusion in dogs. 2Lactate production was decreased in the presence as compared with the absence of enflurane during demand-induced ischemia produced by a critical coronary artery stenosis and ventricular pacing when coronary perfusion pressure was maintained. 3These results suggested that myocardial metabolism may be improved by administration of a volatile agent during an ischemic episode independent of alterations in hemodynamics. The relative importance of these early findings was initially overshadowed 4by a series of reports published in the mid-1980s 5–8suggesting that isoflurane may be capable of producing an abnormal redistribution of coronary blood flow away from ischemic toward normal myocardium. 9–11This “coronary steal” phenomenon was attributed to the coronary vasodilating properties of isoflurane that are known to occur primarily in arterioles of less than 100 μm in diameter. 12Isoflurane was thought to be capable of directly producing myocardial ischemia in susceptible patients with “steal-prone” coronary artery anatomy under certain hemodynamic conditions 13in a fashion similar to that of potent coronary vasodilators (e.g. , adenosine, chromonar, dipyridamole).The implication that isoflurane might produce myocardial ischemia through such a steal mechanism was subsequently dispelled by several investigations conducted in animal models 14–17and humans with coronary artery disease. 18–20For example, isoflurane did not selectively redistribute blood flow away from the collateral-dependent region in a chronically instrumented canine model of multivessel coronary artery disease. 15In contrast, adenosine produced marked coronary steal by preferentially shunting blood flow away from collateral-dependent myocardium in this model. 15Other studies 14,16–20also suggested that isoflurane-induced hypotension may reduce myocardial perfusion, but true coronary steal did not occur when coronary perfusion pressure was maintained. Subsequent investigations with the newer volatile anesthetics sevoflurane 21,22and desflurane 23showed that these drugs also did not reduce or abnormally redistribute coronary collateral blood flow. Therefore, despite initial concerns, volatile anesthetics were subsequently shown to be relatively weak coronary vasodilators that are incapable of causing coronary steal under the vast majority of clinical conditions. 24Contrary to the hypothesis that the use of volatile anesthetics may be potentially deleterious in some

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00000542-200403000-00035

Cites

82 of 82 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 82 references

Cited by

See all 274

Metadata

Authors
Tanaka, K., Ludwig, L. M., Kersten, J. R., Pagel, P. S., & Warltier, D. C.
Venue
Anesthesiology
Published
2004-03-01
Volume
100
Issue
3
Pages
707-721
ISSN
0003-3022 (ISSN-L)
OpenAlex
W2078907724
Cited by
274
References
82
FWCI
17.54
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mechanisms of Cardioprotection by Volatile Anesthetics. https://app.cochat.ai/papers/10.1097/00000542-200403000-00035
The paper
Tanaka, K., Ludwig, L. M., Kersten, J. R., Pagel, P. S., & Warltier, D. C. (2004). Mechanisms of Cardioprotection by Volatile Anesthetics. Anesthesiology. https://doi.org/10.1097/00000542-200403000-00035

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.